These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25146968)

  • 1. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
    Hassan-Smith G; Durant L; Tsentemeidou A; Assi LK; Faint JM; Kalra S; Douglas MR; Curnow SJ
    J Neuroimmunol; 2014 Nov; 276(1-2):175-9. PubMed ID: 25146968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL; Muls N; van Pesch V
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
    Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
    Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.
    Süße M; Hannich M; Petersmann A; Zylla S; Pietzner M; Nauck M; Dressel A
    Eur J Neurol; 2018 Sep; 25(9):1134-1139. PubMed ID: 29683546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
    Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
    Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
    Kaplan B; Golderman S; Yahalom G; Yeskaraev R; Ziv T; Aizenbud BM; Sela BA; Livneh A
    J Immunol Methods; 2013 Apr; 390(1-2):74-80. PubMed ID: 23376556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.
    Duranti F; Pieri M; Centonze D; Buttari F; Bernardini S; Dessi M
    J Neuroimmunol; 2013 Oct; 263(1-2):116-20. PubMed ID: 23916392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
    Gaetani L; Di Carlo M; Brachelente G; Valletta F; Eusebi P; Mancini A; Gentili L; Borrelli A; Calabresi P; Sarchielli P; Ferri C; Villa A; Di Filippo M
    J Neuroimmunol; 2020 Feb; 339():577108. PubMed ID: 31743879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study.
    Hegen H; Berek K; Cavalla P; Christiansen M; Emeršič A; Di Filippo M; Gaetani L; Hassler M; Leurs C; Milosavljevic D; van Pesch V; Petersen T; Presslauer S; Rosenstein I; Rot U; Schnabl C; Teunissen C; Vecchio D; Vercellino M; Deisenhammer F
    Front Immunol; 2023; 14():1327947. PubMed ID: 38169789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
    Presslauer S; Milosavljevic D; Brücke T; Bayer P; Hübl W
    J Neurol; 2008 Oct; 255(10):1508-14. PubMed ID: 18685917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.
    Hegen H; Berek K; Deisenhammer F
    Wien Med Wochenschr; 2022 Nov; 172(15-16):337-345. PubMed ID: 35133530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of sensitivities and specificities of cerebrospinal fluid free light chains to diagnose multiple sclerosis- a multicentric case-control study.
    Thevarkalam M; Krishnan S; Shanmughan LI; Mathai A; Leelamani JV; Kannoth S; Bhaskaran R; Iype T; Panda S
    Mult Scler Relat Disord; 2023 Jun; 74():104717. PubMed ID: 37062197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands.
    Altinier S; Puthenparampil M; Zaninotto M; Toffanin E; Ruggero S; Gallo P; Plebani M
    Clin Chim Acta; 2019 Sep; 496():117-120. PubMed ID: 31233736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.
    Huss A; Mojib-Yezdani F; Bachhuber F; Fangerau T; Lewerenz J; Otto M; Tumani H; Senel M
    Clin Chim Acta; 2019 Nov; 498():148-153. PubMed ID: 31437445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
    Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H
    Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 19. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis.
    Fischer C; Arneth B; Koehler J; Lotz J; Lackner KJ
    Clin Chem; 2004 Oct; 50(10):1809-13. PubMed ID: 15271859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
    Hegen H; Walde J; Berek K; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
    Mult Scler; 2023 Feb; 29(2):169-181. PubMed ID: 36453167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.